Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score
- PMID: 17714568
- DOI: 10.1111/j.1365-2133.2007.08112.x
Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score
Abstract
It is important to determine the severity of atopic dermatitis (AD) for evaluation of disease improvement after and during therapy. Scoring of the severity of AD is demanded in clinical trials. The European Task Force on Atopic Dermatitis (ETFAD) has developed the SCORAD (SCORing AD) index to create a consensus on assessment methods for AD, so that study results of different trials can be compared. However, modification of the SCORAD index has led on several occasions to wrong and incorrect use of the system. To measure the extent of AD, the rule of nines is applied on a front/back drawing of the patient's inflammatory lesions. The extent can be graded 0-100. The intensity part of the SCORAD index consists of six items: erythema, oedema/papulation, excoriations, lichenification, oozing/crusts and dryness. Each item can be graded on a scale 0-3. The subjective items include daily pruritus and sleeplessness. Both subjective items can be graded on a 10-cm visual analogue scale. The maximum subjective score is 20. All items should be filled out in the SCORAD evaluation form. The SCORAD index formula is: A/5 + 7B/2 + C. In this formula A is defined as the extent (0-100), B is defined as the intensity (0-18) and C is defined as the subjective symptoms (0-20). The maximum SCORAD score is 103. Based on training sessions by the ETFAD, the SCORAD index was modified by excluding the subjective symptoms (objective SCORAD). The objective SCORAD consists of just the extent and intensity items, the formula being A/5 + 7B/2. The maximum objective SCORAD score is 83 (plus an additional 10 bonus points). Bonus points are given for severe disfiguring eczema (on face and hands). The three-item severity (TIS) score involves the scoring of erythema (redness), oedema and excoriations (scratches) in one representative lesion, marked as R-O-S. The TIS score corresponds well with the more detailed objective SCORAD and can be used as a prescreening system or as a quick system in studies and is excellent for epidemiological studies.
Similar articles
-
Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score.Curr Probl Dermatol. 2011;41:149-155. doi: 10.1159/000323308. Epub 2011 May 12. Curr Probl Dermatol. 2011. PMID: 21576955
-
Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index.Allergy. 2005 Jan;60(1):113-6. doi: 10.1111/j.1398-9995.2004.00622.x. Allergy. 2005. PMID: 15575941
-
The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.Br J Dermatol. 2005 Oct;153(4):767-73. doi: 10.1111/j.1365-2133.2005.06697.x. Br J Dermatol. 2005. PMID: 16181458
-
Evaluation of the child with atopic dermatitis.Clin Exp Allergy. 2012 Mar;42(3):352-62. doi: 10.1111/j.1365-2222.2011.03899.x. Epub 2011 Nov 14. Clin Exp Allergy. 2012. PMID: 22093041 Review.
-
Measurement of disease activity and outcome in atopic dermatitis.Br J Dermatol. 1996 Oct;135(4):509-15. Br J Dermatol. 1996. PMID: 8915137 Review.
Cited by
-
Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.JCI Insight. 2022 Mar 8;7(5):e152559. doi: 10.1172/jci.insight.152559. JCI Insight. 2022. PMID: 35113811 Free PMC article.
-
Evaluation of the Impact of Serum Vitamin D Levels on the Scoring Atopic Dermatitis Index in Pediatric Atopic Dermatitis.Children (Basel). 2023 Sep 7;10(9):1522. doi: 10.3390/children10091522. Children (Basel). 2023. PMID: 37761483 Free PMC article.
-
Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved?Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):651-8. doi: 10.1007/s10096-013-2000-z. Epub 2013 Oct 27. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24162256
-
Systemic therapy of atopic dermatitis in children.Drugs. 2009;69(3):297-306. doi: 10.2165/00003495-200969030-00005. Drugs. 2009. PMID: 19275273 Review.
-
Anti-Atopic Dermatitis Effects of Abietic Acid Isolated from Rosin under Condition Optimized by Response Surface Methodology in DNCB-Spread BALB/c Mice.Pharmaceuticals (Basel). 2023 Mar 7;16(3):407. doi: 10.3390/ph16030407. Pharmaceuticals (Basel). 2023. PMID: 36986507 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources